A new book explores how culture, geography, perception, experience, and trust shape responses to weather risks.
If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results